Evidence map›Paper›PMID 34243760›Full record

ArticleJournal of nanobiotechnology2021

Amphiphilic branched polymer-nitroxides conjugate as a nanoscale agent for potential magnetic resonance imaging of multiple objects in vivo.

Xiaoming Wang, Shiwei Guo, Zhiqian Li, Qiang Luo, Yan Dai, Hu Zhang, Yun Ye, Qiyong Gong, Kui Luo

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaoming Wang *Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 610041, Chengdu, China.
Shiwei Guo *Department of Pharmacy of the Affiliated Hospital of Southwest Medical University, Southwest Medical University, Sichuan Province, 646000, Luzhou, People's Republic of China.
Zhiqian LiHuaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 610041, Chengdu, China.
Qiang LuoHuaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 610041, Chengdu, China.
Yan DaiDepartment of Pharmacy of the Affiliated Hospital of Southwest Medical University, Southwest Medical University, Sichuan Province, 646000, Luzhou, People's Republic of China.
Hu ZhangAmgen Bioprocessing Centre, Keck Graduate Institute Claremont, 91711, Claremont, CA, USA.
Yun YeDepartment of Pharmacy of the Affiliated Hospital of Southwest Medical University, Southwest Medical University, Sichuan Province, 646000, Luzhou, People's Republic of China.
Qiyong GongHuaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 610041, Chengdu, China.
Kui LuoHuaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 610041, Chengdu, China. luokui@scu.edu.cn.

Funding

china postdoctoral science foundation 2020TQ0212Doctoral Research Startup Fund of the Affiliated Hospital of Southwest Medical University 19067National Natural Science Foundation of China 51673127National Natural Science Foundation of China 51873120National Natural Science Foundation of China 81621003Natural Science Foundation of Chongqing, China cstc2019jcyj-msxmX0116The Collaborative Project of Luzhou Government and Southwest Medical University 2018LZXNYD-PT02the Open Project Program of Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province HYX20006University level research fund of Southwest Medical University 2019ZQN026
6 · The paper itself

Abstract

backgroundIn order to address the potential toxicity of metal-based magnetic resonance imaging (MRI) contrast agents (CAs), a concept of non-metallic MRI CAs has emerged. Currently, paramagnetic nitroxides (such as (2,2,5,5-tetramethylpyrrolidine-1-oxyl, PROXYL), (2,2,6,6-tetramethylpiperidine-1-oxide, TEMPO), etc.) are being extensively studied because their good stability and imaging mechanism are similar to metal-based contrast agents (such as Gd

resultsBranched pDHPMA-mPEG-Ppa-PROXYL with a high molecular weight (MW = 160 kDa) and a nitroxides content (0.059 mmol/g) can form a nanoscale (~ 28 nm) self-assembled aggregate in a water environment and hydrophobic PROXYL can be protected by a hydrophilic outer layer to obtain strong reduction resistance in vivo. Compared with a small molecular CA (3-Carboxy-PROXYL (3-CP)), Branched pDHPMA-mPEG-Ppa-PROXYL displays three prominent features: (1) its longitudinal relaxivity (0.50 mM

conclusionsAs a safe and efficient candidate metal-free magnetic resonance contrast agent, Branched pDHPMA-mPEG-Ppa-PROXYL is expected to be used not only in imaging the tumor, liver and kidney, but also the cardiovascular system, which expands the application scope of these CAs.

Indexed as

AnimalsCell SurvivalContrast MediaCyclic N-OxidesFemaleGadoliniumHeartKidneyLiverMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMiceMice, Inbred BALB CNanoparticlesNeoplasmsNitrogen Oxides2,2,5,5-tetramethyl-1-pyrrolidinyloxy-3-carboxylic acidContrast MediaCyclic N-OxidesGadoliniumNitrogen OxidesnitroxylPolymersMagnetic resonance imagingMetal-free contrast agentsNitroxidesPolymers

Identifiers

PMID34243760
PMCPMC8272293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.